{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:00:23Z","timestamp":1790636423138,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000785","name":"Education, Audiovisual and Culture Executive Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013414","name":"Conseil R\u00e9gional des Pays de la Loire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Glycoconj J"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10719-021-09999-3","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T04:04:38Z","timestamp":1618373078000},"page":"437-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["On the use of adenovirus dodecahedron as a carrier for glycoconjugate vaccines"],"prefix":"10.1007","volume":"38","author":[{"given":"Maruthi","family":"Prasanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Podsiadla-Bialoskorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Mielecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ruffier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Fateh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Fanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Camberlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Szolajska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9775-6917","authenticated-orcid":false,"given":"Cyrille","family":"Grandjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,14]]},"reference":[{"issue":"1","key":"9999_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.38.1.73","volume":"38","author":"M Heidelberger","year":"1923","unstructured":"Heidelberger, M., Avery, O.T.: The soluble specific substance of pneumococcus. J. Exp. Med. 38(1), 73\u201379 (1923). https:\/\/doi.org\/10.1084\/jem.38.1.73","journal-title":"J. Exp. Med."},{"issue":"456","key":"9999_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1126\/scitranslmed.aat4615","volume":"10","author":"R Rappuoli","year":"2018","unstructured":"Rappuoli, R.: Glycoconjugate vaccines: Principles and mechanisms. Sci. Transl. Med. 10(456), 29 (2018). https:\/\/doi.org\/10.1126\/scitranslmed.aat4615","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"9999_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1073\/pnas.1816401115","volume":"116","author":"X Sun","year":"2019","unstructured":"Sun, X., Stefanetti, G., Berti, F., Kasper, D.L.: Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines. Proc. Natl. Acad. Sci. U S A. 116(1), 193\u2013198 (2019). https:\/\/doi.org\/10.1073\/pnas.1816401115","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"25","key":"9999_CR4","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1016\/j.vaccine.2017.04.078","volume":"35","author":"M Br\u00f6ker","year":"2017","unstructured":"Br\u00f6ker, M., Berti, F., Schneider, J., Vojtek, I.: Polysaccharide conjugate vaccine protein carriers as a \u201cneglected valency\u201d - Potential and limitations. Vaccine. 35(25), 3286\u20133294 (2017). https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.078","journal-title":"Vaccine"},{"key":"9999_CR5","doi-asserted-by":"publisher","unstructured":"Micoli, F., Adamo, R., Costantino, P.: Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends. Molecules. 23(6), (2018). https:\/\/doi.org\/10.3390\/molecules23061451","DOI":"10.3390\/molecules23061451"},{"issue":"11","key":"9999_CR6","doi-asserted-by":"publisher","first-page":"e79304","DOI":"10.1371\/journal.pone.0079304","volume":"8","author":"VB Pinto","year":"2013","unstructured":"Pinto, V.B., Burden, R., Wagner, A., Moran, E.E., Lee, C.-H.: The development of an experimental multiple serogroups vaccine for Neisseria meningitidis. PLoS One. 8(11), e79304 (2013). https:\/\/doi.org\/10.1371\/journal.pone.0079304","journal-title":"PLoS One"},{"issue":"2","key":"9999_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/2049-632X.12022","volume":"67","author":"C Grandjean","year":"2013","unstructured":"Grandjean, C., Wade, T.K., Ropartz, D., Ernst, L., Wade, W.F.: Acid-detoxified Inaba lipopolysaccharide (pmLPS) is a superior cholera conjugate vaccine immunogen than hydrazine-detoxified lipopolysaccharide and induces vibriocidal and protective antibodies. Pathog. Dis. 67(2), 136\u2013158 (2013). https:\/\/doi.org\/10.1111\/2049-632X.12022","journal-title":"Pathog. Dis."},{"issue":"2","key":"9999_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.celrep.2018.09.029","volume":"25","author":"MC Woodruff","year":"2018","unstructured":"Woodruff, M.C., Kim, E.H., Luo, W., Pulendran, B.: B Cell Competition for Restricted T Cell Help Suppresses Rare-Epitope Responses. Cell. Rep. 25(2), 321\u2013327.e3 (2018). https:\/\/doi.org\/10.1016\/j.celrep.2018.09.029","journal-title":"Cell. Rep."},{"key":"9999_CR9","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fchem.2019.00726","volume":"7","author":"A Pillot","year":"2019","unstructured":"Pillot, A., Defontaine, A., Fateh, A., Lambert, A., Prasanna, M., Fanuel, M., Pipelier, M., Csaba, N., Violo, T., Camberlein, E., Grandjean, C.: Site-specific conjugation for fully controlled Glycoconjugate vaccine preparation. Front Chem. 7, 726 (2019). https:\/\/doi.org\/10.3389\/fchem.2019.00726","journal-title":"Front Chem"},{"issue":"1","key":"9999_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1021\/acsnano.6b07343","volume":"11","author":"KT Gause","year":"2017","unstructured":"Gause, K.T., Wheatley, A.K., Cui, J., Yan, Y., Kent, S.J., Caruso, F.: Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery. ACS Nano. 11(1), 54\u201368 (2017). https:\/\/doi.org\/10.1021\/acsnano.6b07343","journal-title":"ACS Nano"},{"key":"9999_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.clim.2017.08.004","volume":"183","author":"V Cimica","year":"2017","unstructured":"Cimica, V., Galarza, J.M.: Adjuvant formulations for virus-like particle (VLP) based vaccines. Clin. Immunol. 183, 99\u2013108 (2017). https:\/\/doi.org\/10.1016\/j.clim.2017.08.004","journal-title":"Clin. Immunol."},{"issue":"24","key":"9999_CR12","doi-asserted-by":"publisher","first-page":"10415","DOI":"10.1007\/s00253-015-7000-8","volume":"99","author":"D Yan","year":"2015","unstructured":"Yan, D., Wei, Y.-Q., Guo, H.-C., Sun, S.-Q.: The application of virus-like particles as vaccines and biological vehicles. Appl. Microbiol. Biotechnol. 99(24), 10415\u201310432 (2015). https:\/\/doi.org\/10.1007\/s00253-015-7000-8","journal-title":"Appl. Microbiol. Biotechnol"},{"issue":"6","key":"9999_CR13","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.cell.2019.01.046","volume":"176","author":"J Marcandalli","year":"2019","unstructured":"Marcandalli, J., et al.: Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus. Cell. 176(6), 1420\u20131431.e17 (2019). https:\/\/doi.org\/10.1016\/j.cell.2019.01.046","journal-title":"Cell"},{"issue":"1","key":"9999_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1021\/acscentsci.0c01405","volume":"7","author":"AE Powell","year":"2021","unstructured":"Powell, A.E., Zhang, K., Sanyal, M., Tang, S., Weidenbacher, P.A., Li, S., Pham, T.D., Pak, J.E., Chiu, W., Kim, P.S.: A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice. ACS Cent. Sci. 7(1), 183\u2013199 (2021). https:\/\/doi.org\/10.1021\/acscentsci.0c01405","journal-title":"ACS Cent. Sci."},{"key":"9999_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/bs.mie.2017.06.030","volume":"597","author":"S Sungsuwan","year":"2017","unstructured":"Sungsuwan, S., Wu, X., Huang, X.: Evaluation of virus-like particle-based tumor-associated carbohydrate Immunogen in a mouse tumor model. Methods Enzymol. 597, 359\u2013376 (2017). https:\/\/doi.org\/10.1016\/bs.mie.2017.06.030","journal-title":"Methods Enzymol."},{"issue":"4","key":"9999_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.chembiol.2010.03.012","volume":"17","author":"RD Astronomo","year":"2010","unstructured":"Astronomo, R.D., et al.: Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds. Chem. Biol. 17(4), 357\u2013370 (2010). https:\/\/doi.org\/10.1016\/j.chembiol.2010.03.012","journal-title":"Chem. Biol."},{"issue":"4","key":"9999_CR17","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1172\/JCI91192","volume":"127","author":"Z Polonskaya","year":"2017","unstructured":"Polonskaya, Z., et al.: T cells control the generation of nanomolar-affinity anti-glycan antibodies. J. Clin. Invest. 127(4), 1491\u20131504 (2017). https:\/\/doi.org\/10.1172\/JCI91192","journal-title":"J. Clin. Invest."},{"issue":"1","key":"9999_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nbt0197-52","volume":"15","author":"P Fender","year":"1997","unstructured":"Fender, P., Ruigrok, R.W., Gout, E., Buffet, S., Chroboczek, J.: Adenovirus dodecahedron, a new vector for human gene transfer. Nat Biotechnol. 15(1), 52\u201356 (1997). https:\/\/doi.org\/10.1038\/nbt0197-52","journal-title":"Nat Biotechnol"},{"issue":"2","key":"9999_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.virol.2004.01.015","volume":"321","author":"RR Viv\u00e8s","year":"2004","unstructured":"Viv\u00e8s, R.R., Lortat-Jacob, H., Chroboczek, J., Fender, P.: Heparan sulfate proteoglycan mediates the selective attachment and internalization of serotype 3 human adenovirus dodecahedron. Virology. 321(2), 332\u2013340 (2004). https:\/\/doi.org\/10.1016\/j.virol.2004.01.015","journal-title":"Virology"},{"issue":"1","key":"9999_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.virol.2007.09.026","volume":"371","author":"P Fender","year":"2008","unstructured":"Fender, P., Schoehn, G., Perron-Sierra, F., Tucker, G.C., Lortat-Jacob, H.: Adenovirus dodecahedron cell attachment and entry are mediated by heparan sulfate and integrins and vary along the cell cycle. Virology. 371(1), 155\u2013164 (2008). https:\/\/doi.org\/10.1016\/j.virol.2007.09.026","journal-title":"Virology"},{"key":"9999_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1472-6750-13-50","volume":"13","author":"A Naskalska","year":"2013","unstructured":"Naskalska, A., Szolajska, E., Andreev, I., Podsiadla, M., Chroboczek, J.: Towards a novel influenza vaccine: engineering of hemagglutinin on a platform of adenovirus dodecahedron. BMC Biotechnol. 13, 50 (2013). https:\/\/doi.org\/10.1186\/1472-6750-13-50","journal-title":"BMC Biotechnol."},{"issue":"40","key":"9999_CR22","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1016\/j.vaccine.2013.07.021","volume":"31","author":"I Szurgot","year":"2013","unstructured":"Szurgot, I., et al.: Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform. Vaccine. 31(40), 4338\u20134346 (2013). https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.021","journal-title":"Vaccine"},{"key":"9999_CR23","doi-asserted-by":"publisher","unstructured":"Vragniau, C., Bufton, J. C., Garzoni, F., Stermann, E., Rabi, F., Terrat, C., Guidetti, M., Josserand, V., Williams, M., Woods, C.J., Viedma, G., Bates, P., Verrier, B., Chaperot, L., Schaffitzel, C., Berger, I., Fender, P. Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display. Sci. Adv. 5(9), eaaw2853 (2019).\u00a0https:\/\/doi.org\/10.1126\/sciadv.aaw2853","DOI":"10.1126\/sciadv.aaw2853"},{"key":"9999_CR24","doi-asserted-by":"publisher","unstructured":"Szurgot, I., Jedynak, M., Podsiadla-Bialoskorska, M., Piwowarski, J., Szolajska, E., Chroboczek, J.: Adenovirus Dodecahedron, a VLP, Can be Purified by Size Exclusion Chromatography Instead of Time-Consuming Sucrose Density Gradient Centrifugation. Mol. Biotechnol. 57(6), 565\u2013573 (2015). https:\/\/doi.org\/10.1007\/s12033-015-9850-9","DOI":"10.1007\/s12033-015-9850-9"},{"key":"9999_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejps.2018.12.013","volume":"129","author":"M Prasanna","year":"2019","unstructured":"Prasanna, M., et al.: Semisynthetic glycoconjugate based on dual role protein\/PsaA as a pneumococcal vaccine. Eur. J. Pharm. Sci. 129, 31\u201341 (2019). https:\/\/doi.org\/10.1016\/j.ejps.2018.12.013","journal-title":"Eur. J. Pharm. Sci."},{"key":"9999_CR26","doi-asserted-by":"publisher","unstructured":"Herbert, D., Phipps,\u00a0P. J.,\u00a0Strange,\u00a0R. E.,\u00a0Chapter III Chemical Analysis of Microbial Cells. In: Methods in Microbiology, 5, J. R. Norris, D. W. Ribbons, \u00c9d. Academic Press,\u00a0209\u2013344 (1971).\u00a0https:\/\/doi.org\/10.1016\/S0580-9517(08)70641-X","DOI":"10.1016\/S0580-9517(08)70641-X"},{"key":"9999_CR27","doi-asserted-by":"publisher","unstructured":"Grandjean, C., Boutonnier, A., Dassy, B., Fournier, J.-M., Mulard, L.A.: Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba. Glycoconj J. 26(1), 41\u201355 (2009). https:\/\/doi.org\/10.1007\/s10719-008-9160-6","DOI":"10.1007\/s10719-008-9160-6"},{"issue":"2","key":"9999_CR28","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jmb.2005.11.048","volume":"356","author":"P Fuschiotti","year":"2006","unstructured":"Fuschiotti, P., et al.: Structure of the dodecahedral penton particle from human adenovirus type 3. J. Mol. Biol. 356(2), 510\u2013520 (2006). https:\/\/doi.org\/10.1016\/j.jmb.2005.11.048","journal-title":"J. Mol. Biol."},{"issue":"10","key":"9999_CR29","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1128\/IAI.00472-08","volume":"76","author":"D Safari","year":"2008","unstructured":"Safari, D., et al.: Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14. Infect. Immun. 76(10), 4615\u20134623 (2008). https:\/\/doi.org\/10.1128\/IAI.00472-08","journal-title":"Infect. Immun."},{"key":"9999_CR30","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fimmu.2017.00659","volume":"8","author":"EA Kurbatova","year":"2017","unstructured":"Kurbatova, E.A., Akhmatova, N.K., Akhmatova, E.A., Egorova, N.B., Yastrebova, N.E., Sukhova, E.V., Yashunsky, D.V., Tsvetkov, Y.E., Gening, M.L., Nifantiev, N.E.: Neoglycoconjugate of Tetrasaccharide representing one repeating unit of the Streptococcus pneumoniae type 14 capsular polysaccharide induces the production of opsonizing IgG1 antibodies and possesses the highest protective activity as compared to Hexa- and Octasaccharide conjugates. Front. Immunol. 8, 659 (2017). https:\/\/doi.org\/10.3389\/fimmu.2017.00659","journal-title":"Front. Immunol."},{"issue":"9","key":"9999_CR31","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1073\/pnas.96.9.5194","volume":"96","author":"V Pozsgay","year":"1999","unstructured":"Pozsgay, V., Chu, C., Pannell, L., Wolfe, J., Robbins, J.B., Schneerson, R.: Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1. Proc. Natl. Acad. Sci. U S A. 96(9), 5194\u20135197 (1999). https:\/\/doi.org\/10.1073\/pnas.96.9.5194","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"6","key":"9999_CR32","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/infdis\/jiz551","volume":"221","author":"F Carboni","year":"2020","unstructured":"Carboni, F., et al.: Evaluation of Immune Responses to Group B Streptococcus Type III Oligosaccharides Containing a Minimal Protective Epitope. J. Infect. Dis. 221(6), 943\u2013947 (2020). https:\/\/doi.org\/10.1093\/infdis\/jiz551","journal-title":"J. Infect. Dis."},{"issue":"9","key":"9999_CR33","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1128\/iai.70.9.5107-5114.2002","volume":"70","author":"F Mawas","year":"2002","unstructured":"Mawas, F., Niggemann, J., Jones, C., Corbel, M.J., Kamerling, J.P., Vliegenthart, J.F.G.: Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197. Infect. Immun. 70(9), 5107\u20135114 (2002). https:\/\/doi.org\/10.1128\/iai.70.9.5107-5114.2002","journal-title":"Infect. Immun."},{"issue":"42","key":"9999_CR34","doi-asserted-by":"publisher","first-page":"8524","DOI":"10.1039\/c2ob26131f","volume":"10","author":"O Milhomme","year":"2012","unstructured":"Milhomme, O., et al.: Synthesis and immunochemical evaluation of a non-methylated disaccharide analogue of the anthrax tetrasaccharide. Org. Biomol. Chem. 10(42), 8524\u20138532 (2012). https:\/\/doi.org\/10.1039\/c2ob26131f","journal-title":"Org. Biomol. Chem."},{"issue":"1","key":"9999_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00304949709355171","volume":"29","author":"JM Khurana","year":"1997","unstructured":"Khurana, J.M., Gogia, A.: Synthetically Useful Reactions with Nickel Boride. a Review. Org. Preparations Proced. Int. 29(1), 1\u201332 (1997). https:\/\/doi.org\/10.1080\/00304949709355171","journal-title":"Org. Preparations Proced. Int."},{"issue":"13","key":"9999_CR36","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E.F., et al.: UCSF Chimera--a visualization system for exploratory research and analysis. J. Comput. Chem. 25(13), 1605\u20131612 (2004). https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J. Comput. Chem."},{"issue":"9","key":"9999_CR37","doi-asserted-by":"publisher","first-page":"e46075","DOI":"10.1371\/journal.pone.0046075","volume":"7","author":"E Szolajska","year":"2012","unstructured":"Szolajska, E., et al.: The structural basis for the integrity of adenovirus Ad3 dodecahedron. PLoS One. 7(9), e46075 (2012). https:\/\/doi.org\/10.1371\/journal.pone.0046075","journal-title":"PLoS One"},{"key":"9999_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2017.12.003","volume":"245","author":"X Wang","year":"2018","unstructured":"Wang, X., et al.: Immune protection efficacy of FAdV-4 surface proteins fiber-1, fiber-2, hexon and penton base. Virus Res. 245, 1\u20136 (2018). https:\/\/doi.org\/10.1016\/j.virusres.2017.12.003","journal-title":"Virus Res"},{"issue":"19","key":"9999_CR39","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1046\/j.1432-1327.2000.01684.x","volume":"267","author":"HP Bal","year":"2000","unstructured":"Bal, H.P., Chroboczek, J., Schoehn, G., Ruigrok, R.W., Dewhurst, S.: Adenovirus type 7 penton purification of soluble pentamers from Escherichia coli and development of an integrin-dependent gene delivery system. Eur J Biochem. 267(19), 6074\u20136081 (2000). https:\/\/doi.org\/10.1046\/j.1432-1327.2000.01684.x","journal-title":"Eur J Biochem"},{"key":"9999_CR40","unstructured":"\u00ab Default of the coating can be ruled out since a response has been observed for positive controls - positive sera from previous immunizations - which are added in every tested ELISA plate \u00bb"},{"issue":"12","key":"9999_CR41","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/0264-410x(92)90046-m","volume":"10","author":"CC Peeters","year":"1992","unstructured":"Peeters, C.C., Tenbergen-Meekes, A.M., Poolman, J.T., Zegers, B.J., Rijkers, G.T.: Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide--protein conjugate vaccine is decreased by admixture of high doses of free saccharide. Vaccine. 10(12), 833\u2013840 (1992). https:\/\/doi.org\/10.1016\/0264-410x(92)90046-m","journal-title":"Vaccine"},{"issue":"20","key":"9999_CR42","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/s0264-410x(98)00129-7","volume":"16","author":"ME Rodriguez","year":"1998","unstructured":"Rodriguez, M.E., et al.: Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response. Vaccine. 16(20), 1941\u20131949 (1998). https:\/\/doi.org\/10.1016\/s0264-410x(98)00129-7","journal-title":"Vaccine"},{"issue":"1","key":"9999_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.18632\/oncotarget.19944","volume":"9","author":"Z Ma","year":"2018","unstructured":"Ma, Z., Zhang, H., Wang, P.G., Liu, X.-W., Chen, M.: Peptide adjacent to glycosylation sites impacts immunogenicity of glycoconjugate vaccine. Oncotarget. 9(1), 75\u201382 (2018). https:\/\/doi.org\/10.18632\/oncotarget.19944","journal-title":"Oncotarget"},{"issue":"2","key":"9999_CR44","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.vaccine.2014.11.026","volume":"33","author":"S Pecetta","year":"2015","unstructured":"Pecetta, S., et al.: Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation. Vaccine. 33(2), 314\u2013320 (2015). https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.026","journal-title":"Vaccine"},{"key":"9999_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","volume":"34","author":"CG Vinuesa","year":"2016","unstructured":"Vinuesa, C.G., Linterman, M.A., Yu, D., MacLennan, I.C.M.: Follicular Helper T Cells. Annu. Rev. Immunol. 34, 335\u2013368 (2016). https:\/\/doi.org\/10.1146\/annurev-immunol-041015-055605","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"9999_CR46","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.vaccine.2019.12.023","volume":"38","author":"S Sterrett","year":"2020","unstructured":"Sterrett, S., et al.: Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individuals. Vaccine. 38(7), 1778\u20131786 (2020). https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.023","journal-title":"Vaccine"},{"issue":"4","key":"9999_CR47","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.immuni.2018.08.012","volume":"49","author":"S Hong","year":"2018","unstructured":"Hong, S., et al.: B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen. Immunity. 49(4), 695\u2013708.e4 (2018). https:\/\/doi.org\/10.1016\/j.immuni.2018.08.012","journal-title":"Immunity"}],"container-title":["Glycoconjugate Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-021-09999-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10719-021-09999-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-021-09999-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T11:30:39Z","timestamp":1625571039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10719-021-09999-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,14]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["9999"],"URL":"https:\/\/doi.org\/10.1007\/s10719-021-09999-3","relation":{},"ISSN":["0282-0080","1573-4986"],"issn-type":[{"value":"0282-0080","type":"print"},{"value":"1573-4986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,14]]},"assertion":[{"value":"23 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The animal study was reviewed and approved by ethical permit number from Comit\u00e9 d\u2019Ethique en Exp\u00e9rimentation Animale (CEEA): 7897.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}